CompletedNot Applicable

The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

United States590 participantsStarted 2017-10-30

Plain-language summary

To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \> 18 y/o
✓. Unilateral or bilateral pleural effusion
✓. Ability to provide consent or consent given for the procedure and research study

What they're measuring

Risk of bleeding

Timeframe: 2 years

Trial details

NCT IDNCT03535883

SponsorYale University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-01-01

View on ClinicalTrials.gov More Pleural Effusion trials